Regulation of Complement Factor H (CFH) by Multiple miRNAs in Alzheimer’s Disease (AD) Brain

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Molecular Neurobiology

• Publication date

  2012-02-03

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s12035-012-8234-4PMID 22302353PMCID PMC3703615
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• NF- κ B-regulated micro RNAs (miRNAs) in primary human brain cells

  2012cited by this paper
• miRNA-155 upregulation and complement factor H deficits in Down’s syndrome

  2012cited by this paper
• Genetics of Age-Related Macular Degeneration: Current Concepts, Future Directions

  2011cited by this paper
• MicroRNAs in NF-kappaB signaling.

  2011cited by this paper
• Differential expression of miRNA-146a-regulated inflammatory genes in human primary neural, astroglial and microglial cells.

  2011cited by this paper
• Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma

  2011influential reference
• MicroRNAs in CNS injury: Potential roles and therapeutic implications

  2011influential reference
• The synapsins: multitask modulators of neuronal development.

  2011cited by this paper
• Retinal amyloid peptides and complement factor H in transgenic models of Alzheimer's disease

  2011cited by this paper
• Phospholipases A2 and neural membrane dynamics: implications for Alzheimer’s disease

  2011cited by this paper
• Toll-like receptors in health and disease in the brain: mechanisms and therapeutic potential.

  2011cited by this paper
• Return to homeostasis: downregulation of NF-κB responses

  2011cited by this paper
• Membrane proteases and tetraspanins.

  2011cited by this paper
• Novel IκB kinase inhibitors for treatment of nuclear factor-κB-related diseases

  2011cited by this paper
• Inflammatory, Apoptotic, and Survival Gene Signaling in Alzheimer’s Disease

  2010cited by this paper
• The interleukin-1 receptor-associated kinases: critical regulators of innate immune signalling.

  2010cited by this paper
• Omega-3 Essential Fatty Acids Modulate Initiation and Progression of Neurodegenerative Disease

  2010cited by this paper
• Acyclovir or Aβ42 peptides attenuate HSV-1-induced miRNA-146a levels in human primary brain cells

  2010cited by this paper
• Micro RNA-125b (miRNA-125b) function in astrogliosis and glial cell proliferation.

  2010cited by this paper
• Mammalian microRNAs predominantly act to decrease target mRNA levels

  2010cited by this paper
• and Alzheimer's disease

  2010cited by this paper
• Non‐coding RNAs: regulators of disease

  2010cited by this paper
• Regulation of mRNA translation and stability by microRNAs.

  2010cited by this paper
• Export of microRNAs and microRNA-protective protein by mammalian cells

  2010influential reference
• Differential Regulation of Interleukin-1 Receptor-associated Kinase-1 (IRAK-1) and IRAK-2 by MicroRNA-146a and NF-κB in Stressed Human Astroglial Cells and in Alzheimer Disease*

  2010cited by this paper
• Plasma biomarkers for mild cognitive impairment and Alzheimer's disease.

  2009cited by this paper
• NF-kappaB dimers in the regulation of neuronal survival.

  2009cited by this paper
• microRNAs and the immune response

  2009influential reference
• Tetraspanin12 regulates ADAM10‐dependent cleavage of amyloid precursor protein

  2009cited by this paper
• Micro-RNA abundance and stability in human brain: specific alterations in Alzheimer's disease temporal lobe neocortex.

  2009cited by this paper
• HSV-1 infection of human brain cells induces miRNA-146a and Alzheimer-type inflammatory signaling

  2009cited by this paper
• MicroRNAs in brain development and physiology.

  2009cited by this paper
• Characterization of an NF-kappaB-regulated, miRNA-146a-mediated down-regulation of complement factor H (CFH) in metal-sulfate-stressed human brain cells.

  2009cited by this paper
• Protein components of the microRNA pathway and human diseases.

  2009influential reference
• Complement Factor H, a Marker of Self Protects against Experimental Autoimmune Encephalomyelitis1

  2009cited by this paper
• NFκB-mediated metabolic inflammation in peripheral tissues versus central nervous system

  2009cited by this paper
• NFkappaB-mediated metabolic inflammation in peripheral tissues versus central nervous system.

  2009cited by this paper
• An NF-κB-sensitive Micro RNA-146a-mediated Inflammatory Circuit in Alzheimer Disease and in Stressed Human Brain Cells*

  2008cited by this paper
• Altered neuronal gene expression in brain regions differentially affected by Alzheimer's disease: a reference data set.

  2008cited by this paper
• MicroRNA in schizophrenia: Genetic and expression analysis of miR-130b (22q11)

  2007influential reference
• Induction of specific micro RNA (miRNA) species by ROS-generating metal sulfates in primary human brain cells.

  2007cited by this paper
• The synapsin cycle: A view from the synaptic endocytic zone

  2007cited by this paper
• The simple design of complement factor H: Looks can be deceiving.

  2007cited by this paper
• Natural secretory products of human neural and microvessel endothelial cells

  2007cited by this paper
• Micro-RNA speciation in fetal, adult and Alzheimer's disease hippocampus

  2007cited by this paper
• Regulations and roles of the interleukin-1 receptor associated kinases (IRAKs) in innate and adaptive immunity

  2006cited by this paper
• NF-κB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses

  2006cited by this paper
• Inflammation and neurodegenerative diseases.

  2006cited by this paper
• Physiological functions for brain NF-κB

  2005cited by this paper
• Physiological functions for brain NF-kappaB.

  2005cited by this paper
• In vivo approaches and rationale for quantifying kinetics and imaging brain lipid metabolic pathways.

  2005cited by this paper
• Nanomolar aluminum induces pro-inflammatory and pro-apoptotic gene expression in human brain cells in primary culture.

  2005cited by this paper
• A role for docosahexaenoic acid-derived neuroprotectin D1 in neural cell survival and Alzheimer disease.

  2005cited by this paper
• Gene Expression Profiling in Fetal, Aged, and Alzheimer Hippocampus: A Continuum of Stress-Related Signaling

  2004cited by this paper
• The functions of animal microRNAs

  2004cited by this paper
• Cyclooxygenase-3 Gene Expression in Alzheimer Hippocampus and in Stressed Human Neural Cells

  2004cited by this paper
• Gene expression profiling of 12633 genes in Alzheimer hippocampal CA1: Transcription and neurotrophic factor down‐regulation and up‐regulation of apoptotic and pro‐inflammatory signaling

  2002cited by this paper
• A Gene Expression Profile of Alzheimer's Disease

  2001influential reference
• Gene Expression Analyzed by Microarrays in HSV-1 Latent Mouse Trigeminal Ganglion Following Heat Stress

  2001cited by this paper
• Run-on gene transcription in human neocortical nuclei

  1998cited by this paper
• Strong nuclear factor‐κB‐DNA binding parallels cyclooxygenase‐2 gene transcription in aging and in sporadic alzheimer's disease superior temporal lobe neocortex

  1998cited by this paper
• BC200 RNA in normal human neocortex, non-Alzheimer dementia (NAD), and senile dementia of the Alzheimer type (AD)

  1992cited by this paper

• MicroRNA-mediated post-transcriptional regulation in the pathogenesis of multiple sclerosis

  2026cites this paper
• Emerging pathological mechanisms of Alzheimer’s disease pathogenesis: from neuroimmune interactions to intercellular communication

  2026cites this paper
• Sex‐ and region‐dependent neuroinflammation in Alzheimer's disease

  2025cites this paper
• The Multifaceted Role of Neuroprotectin D1: Physiological, Pathophysiological, and Pharmacological Insights in Neurodegenerative Diseases

  2025cites this paper
• Potential interactions between STING pathway and the complement system in immune regulation

  2025cites this paper
• The complement cascade in Alzheimer’s disease: modern implications of an ancient immune protagonist

  2025cites this paper
• Epigenetic Biomarkers in Alzheimer's Disease: Diagnostic and Prognostic Relevance.

  2024cites this paper
• Demystifying the Role of Neuroinflammatory Mediators as Biomarkers for Diagnosis, Prognosis, and Treatment of Alzheimer's Disease: A Review.

  2024cites this paper
• Relationship between the cGAS-STING and NF-κB pathways-role in neurotoxicity.

  2024cites this paper
• The Impact of Juvenile Microglia Transcriptomics on the Adult Brain Regeneration after Cerebral Ischemia

  2024cites this paper
• Exploring the role of miR-125b-5p as a pro-inflammatory factor in Alzheimer's disease pathology

  2024cites this paper
• The neuroinflammatory role of microRNAs in Alzheimer’s disease: pathological insights to therapeutic potential

  2024cites this paper
• The regulation of miRNAs using curcumin and other polyphenols during the prevention and treatment of Alzheimer's disease.

  2024cites this paper
• Neuroglia Cells Transcriptomic in Brain Development, Aging and Neurodegenerative Diseases

  2023cites this paper
• MicroRNA networks linked with BRCA1/2, PTEN, and common genes for Alzheimer's disease and breast cancer share highly enriched pathways that may unravel targets for the AD/BC comorbidity treatment

  2023cites this paper
• Unraveling the role of miRNAs in the diagnosis, progression, and therapeutic intervention of Alzheimer's disease.

  2023cites this paper
• MicroRNAs as potential biomarkers and therapeutic targets in age-related macular degeneration

  2023cites this paper
• ISGylation is induced in neurons by demyelination driving ISG15-dependent microglial activation

  2022cites this paper
• The Expression of miRNAs Involved in Long-Term Memory Formation in the CNS of the Mollusk Helix lucorum

  2022cites this paper
• PICALM and Alzheimer’s Disease: An Update and Perspectives

  2022cites this paper
• Complement component 3 and complement factor H protein levels are altered in brain tissues from people with human immunodeficiency virus: A pilot study

  2022influential citation
• The Pivotal Role of NF-kB in the Pathogenesis and Therapeutics of Alzheimer’s Disease

  2022cites this paper
• MicroRNAs in Learning and Memory and Their Impact on Alzheimer’s Disease

  2022cites this paper
• Diagnostic, Prognostic, and Mechanistic Biomarkers of Diabetes Mellitus-Associated Cognitive Decline

  2022cites this paper
• MRTF-A-mediated protection against amyloid-β-induced neuronal injury correlates with restoring autophagy via miR-1273g-3p/mTOR axis in Alzheimer models

  2022cites this paper
• Dysregulated miRNAs as Biomarkers and Therapeutical Targets in Neurodegenerative Diseases

  2022influential citation
• Label-free Quantitative Proteomic Analysis of Cerebrospinal Fluid and Serum in Patients With Relapse-Remitting Multiple Sclerosis

  2022cites this paper
• MicroRNA modulation is a potential molecular mechanism for neuroprotective effects of intranasal insulin administration in amyloid βeta oligomer induced Alzheimer's like rat model.

  2022cites this paper
• Advances in the development of new biomarkers for Alzheimer’s disease

  2022cites this paper
• Extracellular vesicles with diagnostic and therapeutic potential for prion diseases

  2022cites this paper
• Role of miRNAs in Neurodegeneration: From Disease Cause to Tools of Biomarker Discovery and Therapeutics

  2022cites this paper
• The Complement System in the Central Nervous System: From Neurodevelopment to Neurodegeneration

  2022cites this paper
• Posttranscriptional Regulation of Insulin Resistance: Implications for Metabolic Diseases

  2022cites this paper
• Inflamma-MicroRNAs in Alzheimer’s Disease: From Disease Pathogenesis to Therapeutic Potentials

  2021cites this paper
• Screening key genes and signaling pathways in COVID-19 infection and its associated complications by integrated bioinformatics analysis

  2021cites this paper
• MicroRNAs in Prion Diseases—From Molecular Mechanisms to Insights in Translational Medicine

  2021cites this paper
• miR-146a Dysregulates Energy Metabolism During Neuroinflammation

  2021cites this paper
• In-depth Site-specific Analysis of N-glycoproteome in Human Cerebrospinal Fluid and Glycosylation Landscape Changes in Alzheimer's Disease

  2021cites this paper
• MicroRNA-146a switches microglial phenotypes to resist the pathological processes and cognitive degradation of Alzheimer's disease

  2021cites this paper
• Direct and Indirect Action of Liposomal Form of MIR-101 on Cells in the Experimental Model of Alzheimer’s Disease

  2021cites this paper
• The Regulation of microRNAs in Alzheimer's Disease

  2020cites this paper
• Blood brain barrier inflammation and potential therapeutic role of phytochemicals

  2020cites this paper
• Inhibition of microRNA-155 Protects Retinal Function Through Attenuation of Inflammation in Retinal Degeneration

  2020influential citation
• Promotion of the immunomodulatory properties and osteogenic differentiation of adipose‐derived mesenchymal stem cells in vitro by lentivirus‐mediated mir‐146a sponge expression

  2020cites this paper
• microRNA-Based Biomarkers in Alzheimer’s Disease (AD)

  2020cites this paper
• A hypothesis-generating scoping review of miRs identified in both multiple sclerosis and dementia, their protein targets, and miR signaling pathways.

  2020cites this paper
• MicroRNA Alterations in a Tg501 Mouse Model of Prion Disease

  2020cites this paper
• miR-146a and miR-181a are involved in the progression of mild cognitive impairment to Alzheimer's disease.

  2019cites this paper
• Lipopolysaccharide-stimulated, NF-kB-, miRNA-146a- and miRNA-155-mediated molecular-genetic communication between the human gastrointestinal tract microbiome and the brain.

  2019cites this paper
• Addressing Alzheimer’s Disease (AD) Neuropathology Using Anti-microRNA (AM) Strategies

  2019cites this paper
• MicroRNAs in Neuroinflammation: Implications in Disease Pathogenesis, Biomarker Discovery and Therapeutic Applications

  2019cites this paper
• Altered expression patterns of complement factor H and miR‐146a genes in acute‐chronic phases in experimental autoimmune encephalomyelitis mouse

  2019cites this paper
• Function of complement factor H and imaging of small molecules by MALDI‐MSI in a methamphetamine behavioral sensitization model

  2019cites this paper
• miR-15b-5p targeting amyloid precursor protein is involved in the anti-amyloid eflect of curcumin in swAPP695-HEK293 cells

  2019cites this paper
• microRNA diagnostic panel for Alzheimer's disease and epigenetic trade-off between neurodegeneration and cancer.

  2019cites this paper
• MicroRNA-146a protects against cognitive decline induced by surgical trauma by suppressing hippocampal neuroinflammation in mice.

  2019cites this paper
• Stem Cell-Derived Neurons as Cellular Models of Sporadic Alzheimer’s Disease

  2019cites this paper
• Systematic Review of miRNA as Biomarkers in Alzheimer’s Disease

  2019cites this paper
• Complement factor H levels are decreased and correlated with serum C-reactive protein in late-onset Alzheimer's disease

  2019cites this paper
• miR-125b suppresses cell proliferation and metastasis by targeting HAX-1 in esophageal squamous cell carcinoma.

  2019cites this paper
• A miRNA-Based Blood and Mucosal Approach for Detecting and Monitoring Celiac Disease

  2019cites this paper
• MicroRNA-132 promotes neurons cell apoptosis and activates Tau phosphorylation by targeting GTDC-1 in Alzheimer's disease.

  2019cites this paper
• Deregulation of neuronal miRNAs induced by amyloid-β or TAU pathology

  2018cites this paper
• The Role of microRNAs in Alzheimer’s Disease and Their Therapeutic Potentials

  2018cites this paper
• Microbiome-Mediated Upregulation of MicroRNA-146a in Sporadic Alzheimer’s Disease

  2018cites this paper
• Bacteroidetes Neurotoxins and Inflammatory Neurodegeneration

  2018cites this paper
• Amyloid Beta 1–42 Alters the Expression of miRNAs in Cortical Neurons

  2018cites this paper
• Genome-wide analysis of genetic predisposition to Alzheimer’s disease and related sex disparities

  2018cites this paper
• RNA metabolism in neurodegenerative disease

  2017cites this paper
• Linking deregulation of non-coding RNA to the core pathophysiology of Alzheimer's disease: An integrative review.

  2017cites this paper
• Rethinking Disease Care and Health Care in today ’ s Modern Society

  2017cites this paper
• NeurimmiRs and Postoperative Delirium in Elderly Patients Undergoing Total Hip/Knee Replacement: A Pilot Study

  2017cites this paper
• Towards the application of precision medicine in Age‐Related Macular Degeneration

  2017cites this paper
• RNA expression in human retina

  2017cites this paper
• MicroRNAs, Aging, Cellular Senescence, and Alzheimer's Disease.

  2017cites this paper
• Transcriptomic profiling of platelet senescence and platelet extracellular vesicles

  2017cites this paper
• A critical evaluation of neuroprotective and neurodegenerative MicroRNAs in Alzheimer's disease.

  2017cites this paper
• miRNA expression profile is altered differentially in the rat brain compared to blood after experimental exposure to 50 Hz and 1 mT electromagnetic field.

  2017cites this paper
• Andrographolide attenuates microglia-mediated Aβ neurotoxicity partially through inhibiting NF-κB and JNK MAPK signaling pathway

  2017cites this paper
• Alzheimers Disease Current and Future Perspectives

  2016cites this paper
• Role of MicroRNA in Governing Synaptic Plasticity

  2016cites this paper
• Identification and characteristic of three members of the C1q/TNF-related proteins (CTRPs) superfamily in Eudontomyzon morii.

  2016cites this paper
• Analysis of RNA from Alzheimer’s Disease Post-mortem Brain Tissues

  2016cites this paper
• Identification of microRNAs with Dysregulated Expression in Status Epilepticus Induced Epileptogenesis

  2016cites this paper
• Downregulated serum miR‐223 servers as biomarker in Alzheimer's disease

  2016cites this paper
• CSF complement 3 and factor H are staging biomarkers in Alzheimer’s disease

  2016cites this paper
• Shared Biologic Pathways Between Alzheimer Disease and Major Depression: A Systematic Review of MicroRNA Expression Studies.

  2016cites this paper
• Modulation of miR-146a/complement factor H-mediated inflammatory responses in a rat model of temporal lobe epilepsy

  2016cites this paper
• Inferring of miRNAs as Biomarker via Subspace Dimensionality Reduction and Clustering

  2016cites this paper
• Sulforaphane exerts its anti-inflammatory effect against amyloid-β peptide via STAT-1 dephosphorylation and activation of Nrf2/HO-1 cascade in human THP-1 macrophages.

  2016cites this paper
• Elevated serum miR-106b and miR-146a in patients with focal and generalized epilepsy.

  2016cites this paper
• Role of microRNAs in the regulation of innate immune cells under neuroinflammatory conditions.

  2016cites this paper
• Interaction between microRNA expression and classical risk factors in the risk of coronary heart disease

  2015cites this paper
• Identification of miRNAs in a Model of Retinal Degenerations.

  2015cites this paper
• The emerging role of microRNAs in Alzheimer's disease

  2015influential citation
• MicroRNAs as Potential Signatures of Environmental Exposure or Effect: A Systematic Review

  2015cites this paper
• Circulating microRNAs in Neurodegenerative Diseases.

  2015cites this paper
• Characterisation of novel therapies to mitigate inflammation in retinal degenerations

  2015cites this paper
• Cognitive dysfunction in cancer: Neuroimaging and genetic approaches to identify biological mechanisms

  2015influential citation
• MicroRNA (miRNA) Signaling in the Human CNS in Sporadic Alzheimer’s Disease (AD)-Novel and Unique Pathological Features

  2015cites this paper